I want to thank you all again for welcoming me into your community. Mike's cancer diagnosis has been very unique. As has his treatment. I don't recall what I have already shared, but his actual diagnosis ended up being TPLL (Tcell Prolymphocytic Leukemia). His WBC count went from 432,000 on 9/30 to 530,000 on 10/2. He was admitted in 10/9 as soon as his meds arrived from the UK, his WBC was 535,000.
He is currently on Campath. He had to do a ramp up over 7 days 3mg on first day and then 3, 10, 10, 30, a one day break, and then 30. The drug is amazing and he is responding. The downside is that it explodes his Tcells at such an unbelievable rate that he has a risk of tumor lysis, hence the inpatient for treatment. The life of the drug in his system is 288 hours, so as the drug compounded in his system, so did the slaughter of the cells. His 2nd night of treatment he went into respiratory distress, hypotension, etc. They have to do what I refer to as deploying COUNTERMEASURES. This includes pretreatment for an hour an hour and a half with benadryl a, zofran and solumedrol. Once he starts having a reaction they have to stop the infusion and push allopurinol, rasburicase, and more steroids to prevent the hypercalcemia, hyperkalemia, hyperuricemia, and hyperphosphatemia. Luckily he has had great nurses and was watched carefully. Any time they had to stop the infusion, it was at the very end of the 2 hour drip. He would start with chills and immediately go into rigors. It has been difficult for him and scary, especially the first reaction. The first 30mg dose he was given resulted in a 50 minute episode of rigors, hypertension, and tachycardia. But he made it through. We have infusions 3times a week for 12 weeks at 30mg each.
His body's response to this treatment has been unbelievable. His spleen on CT was measured at 23cm in length and 23cm diameter. It is now slightly below his ribcage. His white count as of Friday 10/23 was 10,670. That is down from 535,000 two weeks earlier. The night of his 50 minute reaction, his WBC count went down by 170,000.
We still just don't know enough about this disease, and most doctors don't see a case of this more than once in 5-10 years, if ever. The average age at diagnosis is 67-70. And most can't survive the treatment, are misdiagnosed, or choose not to treat given their age. It looks as though we will be heading to University of nebraska to discuss a stem cell transplant. The leading expert on this disease is Dr Julie Vose at University of Nebraska and she is consulting with our hematologist regarding his case and treatment.